Lemaitre Vascular (LMAT) Cash & Current Investments (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Cash & Current Investments data on file, last reported at $367.2 million in Q1 2026.

• On a quarterly basis, Cash & Current Investments rose 21.38% year-over-year to $367.2 million in Q1 2026; TTM through Mar 2026 was $367.2 million, a 21.38% increase from a year earlier, with the FY2025 full-year figure at $359.1 million, up 19.82% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $367.2 million, up from $359.1 million in the prior quarter.
• Over the last five years, Cash & Current Investments for LMAT reached as high as $367.2 million in Q1 2026 and fell as low as $70.9 million in Q1 2022.
• Historically, Cash & Current Investments has averaged $177.6 million across 5 years, with a median of $108.3 million in 2024.
• Across the five-year window, Cash & Current Investments jumped 247.87% in 2022 and increased 14.28% in 2023, its largest moves.
• Year by year, Cash & Current Investments stood at $82.7 million in 2022, then rose by 27.07% to $105.1 million in 2023, then soared by 185.25% to $299.7 million in 2024, then gained by 19.82% to $359.1 million in 2025, then grew by 2.26% to $367.2 million in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $367.2 million in Q1 2026, $359.1 million in Q4 2025, and $343.1 million in Q3 2025.